Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abcam Plc ADR (ABCM)

Abcam Plc ADR (ABCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,719,313
  • Shares Outstanding, K 226,781
  • Annual Sales, $ 327,810 K
  • Annual Income, $ 15,760 K
  • 60-Month Beta N/A
  • Price/Sales 11.68
  • Price/Cash Flow N/A
  • Price/Book 5.82
Trade ABCM with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.04 +2.64%
on 08/19/21
21.65 -4.99%
on 09/02/21
-0.03 (-0.15%)
since 08/17/21
3-Month
17.14 +20.01%
on 07/20/21
21.65 -4.99%
on 09/02/21
+1.29 (+6.69%)
since 06/17/21

Most Recent Stories

More News
Abcam to Acquire BioVision for $340 million

Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", "the Company" or "the Group"), a global leader in the supply of life science research tools, today announces that it has entered into a definitive agreement...

ABCZY : 19.4000 (+2.75%)
ABC : 123.47 (-0.61%)
ABCM : 20.57 (-1.15%)
New Strong Sell Stocks for July 29th

ABCM, CCJ, EBMT, MRTN and NESR have been added to the Zacks Rank #5 (Strong Sell) List on July 29, 2021.

CCJ : 22.47 (-6.49%)
MRTN : 15.15 (-3.32%)
EBMT : 21.96 (-0.36%)
NESR : 11.77 (-1.75%)
ABCM : 20.57 (-1.15%)
Abcam opens new US facility in Boston, MA

/PRNewswire/ --  (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in , MA. 

ABC.LN : 1,485.000 (-1.00%)
ABC : 123.47 (-0.61%)
ABCM : 20.57 (-1.15%)
Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients

SOUTH SAN FRANCISCO, Calif. and , /PRNewswire/ -- Today , Inc., a company developing first-in-class antibody therapeutics that increase the body's anti-tumor immunity and (AIM: ABC) (NASDAQ: ABCM),...

ABC.LN : 1,485.000 (-1.00%)
ABCZF : 21.0500 (+0.62%)
ABC : 123.47 (-0.61%)
ABCM : 20.57 (-1.15%)
Microba Life Sciences appoints experienced executive Mark Capone to the Board

, /PRNewswire/ --  has appointed international executive, , as a Non-Executive Director of the Board, bringing with him more than 35 years of experience in the life sciences sector.

ABCM : 20.57 (-1.15%)
Abcam Plc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 8, 2021 / Abcam Plc (NASDAQ:ABCM) will be discussing their earnings results in their 2021 First Half Earnings call to be held on March 8, 2021 at 2:00 PM Eastern Time....

ABCZY : 19.4000 (+2.75%)
ABCM : 20.57 (-1.15%)
Abcam to Report Interim Results on Monday, March 8, 2021

Abcam plc (AIM: ABC; Nasdaq: ABCM) ("Abcam" or the "Company"), a global leader in the supply of life science research tools, will report its Interim Results for the six-month period ended 31 December 2020...

ABCZY : 19.4000 (+2.75%)
ABC : 123.47 (-0.61%)
ABCM : 20.57 (-1.15%)
Abcam to present at the 2021 SVB Leerink Global Healthcare Conference

Abcam plc (Nasdaq: ABCM; LSE: ABC) today announced that Alan Hirzel, Chief Executive Officer, will present at the 2021 SVB Leerink Global Healthcare Conference on Friday, February 26, 2021 at 8.00 EST...

ABCZY : 19.4000 (+2.75%)
ABC : 123.47 (-0.61%)
ABCM : 20.57 (-1.15%)
Abcam Plc Appointment of Non-Executive Directors

Abcam plc (AIM: ABC; Nasdaq: ABCM) ("Abcam"), a global leader in the supply of life science research tools, is delighted to announce the appointments of Bessie Lee and Mark Capone as non-executive Directors...

ABCZY : 19.4000 (+2.75%)
ABC : 123.47 (-0.61%)
ABCM : 20.57 (-1.15%)
Abcam plc Half Year Trading Update

Abcam plc (AIM: ABC; Nasdaq: ABCM) ("Abcam"), a global leader in the supply of life science research tools, announces the following unaudited trading update ahead of reporting its results on 8 March 2021...

ABCZY : 19.4000 (+2.75%)
ABC : 123.47 (-0.61%)
ABCM : 20.57 (-1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Abcam plc is a life sciences company. It researches, develops, and distributes biological reagents and tools for research, drug discovery and diagnostics. The company operates principally in in the United States, China, Japan, Germany, the United Kingdom and internationally. Abcam plc is based in Cambridge,...

See More

Key Turning Points

3rd Resistance Point 21.34
2nd Resistance Point 21.11
1st Resistance Point 20.96
Last Price 20.57
1st Support Level 20.57
2nd Support Level 20.34
3rd Support Level 20.19

See More

52-Week High 24.69
Fibonacci 61.8% 21.81
Fibonacci 50% 20.92
Last Price 20.57
Fibonacci 38.2% 20.02
52-Week Low 17.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar